Spire Wealth Management Has $5.04 Million Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Spire Wealth Management increased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 4,094.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,473 shares of the biotechnology company’s stock after buying an additional 8,271 shares during the quarter. Spire Wealth Management’s holdings in Axon Enterprise were worth $5,036,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. New Wave Wealth Advisors LLC bought a new stake in Axon Enterprise in the fourth quarter valued at approximately $40,000. Quent Capital LLC raised its stake in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares during the period. Prestige Wealth Management Group LLC lifted its holdings in Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the last quarter. Versant Capital Management Inc boosted its position in Axon Enterprise by 4,750.0% during the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock worth $58,000 after purchasing an additional 95 shares during the period. Finally, Berbice Capital Management LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at about $59,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $652.18 on Monday. The stock has a fifty day moving average of $619.63 and a 200-day moving average of $483.68. The stock has a market capitalization of $49.73 billion, a P/E ratio of 168.52, a price-to-earnings-growth ratio of 6.54 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52 week low of $247.04 and a 52 week high of $698.67.

Insiders Place Their Bets

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now directly owns 154,394 shares in the company, valued at $91,691,508.72. The trade was a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 50,545 shares of company stock valued at $30,721,337. 5.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. The Goldman Sachs Group increased their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Finally, Robert W. Baird upped their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $524.85.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.